TRADELABOR has more than 20 years of experience in the control and treatment of air, working with an experienced and qualified technical staff and with the most advanced technology in this area, which together guarantee the quality of the services provided.
PHARMACEUTICAL INDUSTRY RESEARCH AND DEVELOPMENT IN EUROPE
All new medicines introduced into the market are the result of lengthy, costly and risky research and
development (R&D) conducted by pharmaceutical companies:
By the time a medicinal product reaches the market, an average of 12-13 years will have elapsed since the first synthesis of the new active substance;
The cost of researching and developing a new chemical or biological entity was estimated at
€ 1,926 million ($ 2,558 million in year 2013 dollars) in 2016 (DiMasi et al, Journal of Health
Economics, January 2016);
On average, only one to two of every 10,000 substances synthesised in laboratories will
successfully pass all stages of development required to become a marketable medicine
Continue at: https://heatinformatics.com/sites/default/files/images-videosFileContent/efpia-pharmafigures2017_statisticbroch_v04-final.pdf
The text above is owned by the site above referred.
Here is only a small part of the article, for more please follow the link